![](/img/cover-not-exists.png)
A multicenter, randomized, open-label pilot trial assessing the efficacy and safety of etanercept 50 mg twice weekly followed by etanercept 25 mg twice weekly, the combination of etanercept 25 mg twice weekly and acitretin, and acitretin alone in patients with moderate to severe psoriasis
Lee, Joo-Heung, Youn, Jai-Il, Kim, Tae-Yoon, Choi, Jee-Ho, Park, Chul-Jong, Choe, Yong-Beom, Song, Hae-Jun, Kim, Nack-In, Kim, Kwang-Joong, Lee, Jeung-Hoon, Yoo, Hyun-JeongVolume:
16
Language:
english
Journal:
BMC Dermatology
DOI:
10.1186/s12895-016-0048-z
Date:
December, 2016
File:
PDF, 625 KB
english, 2016